FactorPad
Build a Better Process

Stock Risk Measures for Repligen Corp

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 44 for RGEN below.

/ factorpad.com / stocks / f51bbv.html


An ad-free and cookie-free webpage by FactorPad


RGEN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Repligen Corp. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how RGEN stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Pharmaceuticals: Major industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f51bbv.html


RGEN stock risk
REPLIGEN CORP stock beta
RGEN risk report
RGEN f51bbv
RGEN risk analysis
RGEN volatility
REPLIGEN CORP credit risk
RGEN liquidity risk
RGEN leverage
RGEN valuation
RGEN systematic risk
RGEN specific risk
REPLIGEN CORP volatility
RGEN analysis
RGEN financial ratio

This is a new resource, spread the word, tell a friend